Fulcrum Therapeutics FULC
NASDAQ FULC
$3.67 -0.01 (-0.14%)
As of: Oct 2, 2026 · 12:04 PM EDT

Fulcrum Therapeutics (FULC) Shares Outstanding (Diluted) (2020 - 2026)

Updated

Fulcrum Therapeutics' Shares Outstanding (Diluted) came in at 76.26 million for Q2 2026, up 21.9% from 62.54 million a year earlier and up 0.1% from the prior quarter.

Analysis

Fulcrum Therapeutics (FULC) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends

For FY2025, Fulcrum Therapeutics' Shares Outstanding (Diluted) was 63.36 million, up 2.2% from FY2024.

  • Shares Outstanding (Diluted) has increased in each of the last five years, with a five-year compound annual growth rate of 20.1% (FY2020 to FY2025).
  • Going back by year, Shares Outstanding (Diluted) was 61.98 million in FY2024 (+1.1%), 61.31 million in FY2023 (+36.3%), 44.99 million in FY2022 (+27.2%) and 35.36 million in FY2021 (+39.5%).
  • The Q2 2026 figure represents the highest quarterly Shares Outstanding (Diluted) in data going back to Q4 2020.
  • Year-over-year, Shares Outstanding (Diluted) has increased for four consecutive quarters, with growth averaging 6.0% over the last eight quarters.
  • The fastest year-over-year change in Shares Outstanding (Diluted) over five years came in Q1 2022 (growth of 60.3%), and the weakest in Q2 2025 (a decline of 1.6%).
  • Business Quant data shows FULC's Shares Outstanding (Diluted) at 76.22 million (Q1 2026), 63.36 million (Q4 2025) and 62.6 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.44 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.96 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.56 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 544.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 255.20 Mn
10 Fulcrum Therapeutics 282.26 Mn 282.26 Mn - 76.26 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 76.26 Mn
Mar 31, 2026 76.22 Mn
Dec 31, 2025 63.36 Mn
Sep 30, 2025 62.60 Mn
Jun 30, 2025 62.54 Mn
Mar 31, 2025 62.48 Mn
Dec 31, 2024 61.98 Mn
Sep 30, 2024 62.41 Mn
Jun 30, 2024 63.59 Mn
Mar 31, 2024 61.98 Mn
Dec 31, 2023 61.31 Mn
Sep 30, 2023 61.82 Mn
Jun 30, 2023 61.79 Mn
Mar 31, 2023 59.72 Mn
Dec 31, 2022 44.99 Mn
Sep 30, 2022 46.21 Mn
Jun 30, 2022 40.89 Mn
Mar 31, 2022 40.64 Mn
Dec 31, 2021 35.36 Mn
Sep 30, 2021 36.61 Mn
API Access

Fulcrum Therapeutics Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=FULC&period=max&api_key=YOUR_API_KEY